There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Syneos Health Inc (SYNH) and Retrophin (RTRX) with bullish sentiments.
Syneos Health Inc (SYNH)
Credit Suisse analyst Erin Wright maintained a Buy rating on Syneos Health Inc today and set a price target of $58. The company’s shares closed last Monday at $51.16.
According to TipRanks.com, Wright is a 5-star analyst with an average return of 9.2% and a 65.1% success rate. Wright covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Quest Diagnostics Inc, and Fulgent Genetics Inc.
Syneos Health Inc has an analyst consensus of Moderate Buy, with a price target consensus of $68.
See today’s analyst top recommended stocks >>
Retrophin (RTRX)
Canaccord Genuity analyst Michelle Gilson maintained a Buy rating on Retrophin today and set a price target of $23. The company’s shares closed last Monday at $13.56, close to its 52-week low of $11.84.
According to TipRanks.com, Gilson is a 4-star analyst with an average return of 14.7% and a 43.5% success rate. Gilson covers the Healthcare sector, focusing on stocks such as Homology Medicines Inc, Stoke Therapeutics Inc, and Ascendis Pharma.
Retrophin has an analyst consensus of Strong Buy, with a price target consensus of $35.25, which is a 181.8% upside from current levels. In a report released today, Barclays also maintained a Buy rating on the stock with a $20 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
